Impact of Xpert MTB/RIF vs smear microscopy
All‐cause mortality at 6 months (subgroup) · people being investigated for tuberculosis (TB)
Impact of Xpert MTB/RIF showed no clear difference in all‐cause mortality at 6 months (subgroup) compared with smear microscopy (moderate certainty).
1 finding from 1 review
- Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis 2021 · Cochrane Headline outcomes onlyRR 0.98 [0.78, 1.22]3 studies · 8143 participantsModerate